Notice: This company has been marked as potentially delisted and may not be actively trading. Xyratex (XRTX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock XRTX vs. AFMD, HOOK, GOVX, QNTM, MRKR, MTVA, SPRB, IPA, IXHL, and CTXRShould you be buying Xyratex stock or one of its competitors? The main competitors of Xyratex include Affimed (AFMD), Hookipa Pharma (HOOK), GeoVax Labs (GOVX), Quantum Biopharma (QNTM), Marker Therapeutics (MRKR), MetaVia (MTVA), Spruce Biosciences (SPRB), ImmunoPrecise Antibodies (IPA), Incannex Healthcare (IXHL), and Citius Pharmaceuticals (CTXR). These companies are all part of the "pharmaceutical preparations" industry. Xyratex vs. Affimed Hookipa Pharma GeoVax Labs Quantum Biopharma Marker Therapeutics MetaVia Spruce Biosciences ImmunoPrecise Antibodies Incannex Healthcare Citius Pharmaceuticals Affimed (NASDAQ:AFMD) and Xyratex (NASDAQ:XRTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, community ranking, risk, profitability, valuation and earnings. Does the media refer more to AFMD or XRTX? In the previous week, Affimed's average media sentiment score of 0.00 equaled Xyratex'saverage media sentiment score. Company Overall Sentiment Affimed Neutral Xyratex Neutral Is AFMD or XRTX more profitable? Xyratex has a net margin of 0.00% compared to Affimed's net margin of -7,836.26%. Xyratex's return on equity of -146.27% beat Affimed's return on equity.Company Net Margins Return on Equity Return on Assets Affimed-7,836.26% -193.84% -107.24% Xyratex N/A -146.27%-86.83% Does the MarketBeat Community favor AFMD or XRTX? Affimed received 283 more outperform votes than Xyratex when rated by MarketBeat users. Likewise, 70.24% of users gave Affimed an outperform vote while only 63.41% of users gave Xyratex an outperform vote. CompanyUnderperformOutperformAffimedOutperform Votes43970.24% Underperform Votes18629.76% XyratexOutperform Votes15663.41% Underperform Votes9036.59% Which has more risk & volatility, AFMD or XRTX? Affimed has a beta of 2.22, indicating that its stock price is 122% more volatile than the S&P 500. Comparatively, Xyratex has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500. Do analysts rate AFMD or XRTX? Affimed presently has a consensus target price of $13.50, indicating a potential upside of 1,448.17%. Given Affimed's stronger consensus rating and higher possible upside, research analysts plainly believe Affimed is more favorable than Xyratex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Affimed 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Xyratex 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals hold more shares of AFMD or XRTX? 30.8% of Affimed shares are held by institutional investors. Comparatively, 0.2% of Xyratex shares are held by institutional investors. 3.8% of Affimed shares are held by insiders. Comparatively, 6.9% of Xyratex shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has higher earnings and valuation, AFMD or XRTX? Xyratex has lower revenue, but higher earnings than Affimed. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAffimed$877K16.01-$114.66MN/AN/AXyratexN/AN/A-$2.16M-$1.35-0.76 SummaryAffimed beats Xyratex on 8 of the 13 factors compared between the two stocks. Remove Ads Get Xyratex News Delivered to You Automatically Sign up to receive the latest news and ratings for XRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XRTX vs. The Competition Export to ExcelMetricXyratexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.90M$7.13B$5.75B$8.29BDividend YieldN/A2.71%4.39%4.03%P/E Ratio-0.767.3724.8019.35Price / SalesN/A239.72396.7393.25Price / CashN/A65.6738.1634.64Price / Book0.446.787.154.51Net Income-$2.16M$142.63M$3.20B$247.14M Xyratex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XRTXXyratexN/A$1.03flatN/A-76.9%$3.90MN/A-0.76N/AAFMDAffimed3.3941 of 5 stars$0.90+2.2%$13.50+1,401.7%-82.2%$14.47M$877,000.000.00200Upcoming EarningsGap UpHOOKHookipa Pharma2.1848 of 5 stars$1.19+1.7%$23.00+1,832.8%-82.4%$14.35M$43.95M-0.3256Upcoming EarningsGOVXGeoVax Labs2.5238 of 5 stars$1.50-2.6%$14.20+846.7%-33.5%$14.15M$3.09M0.0010Upcoming EarningsNews CoverageQNTMQuantum BiopharmaN/A$7.18+46.8%N/AN/A$13.78MN/A-0.47N/AUpcoming EarningsHigh Trading VolumeMRKRMarker Therapeutics3.9893 of 5 stars$1.28+3.6%$13.50+954.7%-74.5%$13.71M$3.31M0.0060Gap UpMTVAMetaVia1.9358 of 5 stars$1.59+7.4%$12.00+654.7%N/A$13.70MN/A0.0010Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageSPRBSpruce Biosciences2.6715 of 5 stars$0.33-1.4%$2.50+656.7%-53.9%$13.65M$7.10M-0.3520Upcoming EarningsGap UpIPAImmunoPrecise Antibodies1.6463 of 5 stars$0.43+11.5%$5.00+1,065.5%-73.0%$13.33M$24.07M-0.5580Upcoming EarningsIXHLIncannex Healthcare1.3566 of 5 stars$0.74flatN/A-70.5%$13.22M$98,000.00-0.533Positive NewsGap DownCTXRCitius Pharmaceuticals1.8805 of 5 stars$1.53+2.0%$54.50+3,462.1%-92.3%$13.15MN/A0.0020 Remove Ads Related Companies and Tools Related Companies AFMD Alternatives HOOK Alternatives GOVX Alternatives QNTM Alternatives MRKR Alternatives MTVA Alternatives SPRB Alternatives IPA Alternatives IXHL Alternatives CTXR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XRTX) was last updated on 3/24/2025 by MarketBeat.com Staff From Our PartnersThis could put Trump on new $100 billAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xyratex Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Xyratex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
